Loading...
| A04492 | Pages: NA | Aug 2021 | 1796 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Romania Stents Market
Request Now !A stent is a wired mesh tube that aids in keeping coronary arteries open and reduce the risk of a heart attack due to fat deposits in the arteries. They are made of metals, polymers, and natural bioabsorbable materials. They enhance various surgical procedures such as angioplasty or percutaneous coronary intervention (PCI). Moreover, they regulate the blood supply to the heart and are mostly made up of stainless steel. They are implanted in the esophagus to enable the passage of food and beverages in patients suffering from esophageal cancer. In addition, they are inserted in the ureter to prevent obstruction of urine flow from kidney, in the gall bladder to allow passage of bile in patients suffering from gall bladder cancer, and in the abdomen & gastrointestinal tract.
The factors such as increase in usage of stents in minimally invasive surgical procedures and surge in geriatric population in Romania prone to cardiovascular diseases and other chronic ailments fuel the growth of the Romania stents market. For instance, according to European Geriatric Medicine Society, total population of Romania was 21,666,350 in 2015. The percentage of the population aged above 85 years was 1.3% in 2011, and above 65 years was 17% in 2016. Furthermore, , according to Eurostat series, the old age dependency ratio in Romania increased from 21.5 in 2007 to 26.7 in 2017. Moreover, active participation of Romania in initiative taken toward usage of stents boosts the market growth. For instance, Romania is a member of Stent for Life Initiative that ensures the availability of lifesaving indication of primary percutaneous coronary intervention (PPCI) for ST-elevation myocardial infarction patients, which fuels the growth of the Romania stents market. Moreover, companies have shifted their focus on developing technologically advanced stents with the aim of serving a wider audience, thereby propelling the market growth. The coronary stents market trends such as incorporation of micro-sized stents and use of minimally invasive procedures are expected to serve as lucrative opportunities during the forecast period. Furthermore, rise in use of bioresorbable stent, increase in adoption of bifurcated stents, and upsurge in adoption of co-polymers as raw materials are anticipated to provide lucrative opportunities for the market growth across Romania.
However, high cost of treatment associated with stent implants and stringent approval process, as these are highly specialized devices are expected to hinder the market growth.
The Romania stents market is segmented into type and material. Depending on type, the Romania stents market is categorized into coronary stents, peripheral stents and stent-related implants. By material, it is divided into metallic biomaterials, polymers biomaterials and natural biomaterials.
Major players operating in the Romania stents market include Abbott Laboratories, B. Braun Melsungen Ag, Biotronik Se & Co. Kg, Boston Scientific Corporation, C. R. Bard, Inc., Medtronic Plc, Stentys S.A., Terumo Corporation, Microport Scientific Corporation, and Elixir Medical Corporation.
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. PTCA PROCEDURES IN ROMANIA
3.4. AVERAGE SELLING PRICE OF STENTS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
CHAPTER 4 ROMANIA STENTS MARKET, BY TYPE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. CORONARY STENTS
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast
4.2.3. Drug-Eluting Stents (DES)
4.2.3.1. Key market trends, growth factors and opportunities
4.2.3.2. Market size and forecast
4.2.4. Bare-Metal Coronary Stents
4.2.4.1. Key market trends, growth factors and opportunities
4.2.4.2. Market size and forecast
4.2.5. Bioabsorbable Stents
4.2.5.1. Key market trends, growth factors and opportunities
4.2.5.2. Market size and forecast
4.3. PERIPHERAL STENTS
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast
4.3.3. Iliac
4.3.3.1. Key market trends, growth factors and opportunities
4.3.3.2. Market size and forecast
4.3.4. Femoral-Popliteal
4.3.4.1. Key market trends, growth factors and opportunities
4.3.4.2. Market size and forecast
4.3.5. Renal
4.3.5.1. Key market trends, growth factors and opportunities
4.3.5.2. Market size and forecast
4.3.6. Carotid
4.3.6.1. Key market trends, growth factors and opportunities
4.3.6.2. Market size and forecast
4.4. STENT-RELATED IMPLANTS
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast
4.4.3. Synthetic Grafts
4.4.3.1. Key market trends, growth factors and opportunities
4.4.3.2. Market size and forecast
4.4.4. Vena Cava Filters
4.4.4.1. Key market trends, growth factors and opportunities
4.4.4.2. Market size and forecast
CHAPTER 5 ROMANA STENTS MARKET, BY MATERIAL
5.1. OVERVIEW
5.2. METALLIC BIOMATERIALS
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast
5.3. POLYMERS BIOMATERIALS
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast
5.4. NATURAL BIOMATERIALS
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast
CHAPTER 6 COMPANY PROFILES
6.1. ABBOTT LABORATORIES
6.1.1. Operating business segments
6.1.2. Business performance
6.1.3. Key strategic moves and developments
6.2. B. BRAUN MELSUNGEN AG
6.2.1. Operating business segments
6.2.2. Business performance
6.2.3. Key strategic moves and developments
6.3. BIOTRONIK SE & CO. KG
6.3.1. Operating business segments
6.3.2. Business performance
6.3.3. Key strategic moves and developments
6.4. BOSTON SCIENTIFIC CORPORATION
6.4.1. Operating business segments
6.4.2. Business performance
6.4.3. Key strategic moves and developments
6.5. C. R. BARD, INC.
6.5.1. Operating business segments
6.5.2. Business performance
6.5.3. Key strategic moves and developments
6.6. MEDTRONIC PLC
6.6.1. Operating business segments
6.6.2. Business performance
6.6.3. Key strategic moves and developments
6.7. STENTYS S.A.
6.7.1. Operating business segments
6.7.2. Business performance
6.7.3. Key strategic moves and developments
6.8. TERUMO CORPORATION
6.8.1. Operating business segments
6.8.2. Business performance
6.8.3. Key strategic moves and developments
6.9. MICROPORT SCIENTIFIC CORPORATION
6.9.1. Operating business segments
6.9.2. Business performance
6.9.3. Key strategic moves and developments
6.10. ELIXIR MEDICAL CORPORATION
6.10.1. Operating business segments
6.10.2. Business performance
6.10.3. Key strategic moves and developments
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
10%
Discount
10%
Discount
10%
Discount
10%
Discount
Enterprise
License/PDF
10%
Discount
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
